Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marra, G.
Right arrow Articles by Santini, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marra, G.
Right arrow Articles by Santini, S. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:370-375, 2002
© 2002 by the American Diabetes Association, Inc.


Pathophysiology/Complications
Original Article

Early Increase of Oxidative Stress and Reduced Antioxidant Defenses in Patients With Uncomplicated Type 1 Diabetes

A case for gender difference

Giampiero Marra, MD1, Patrizia Cotroneo, MD1, Dario Pitocco, MD1, Andrea Manto, MD1, Mauro A.S. Di Leo, MD1, Valeria Ruotolo, MD1, Salvatore Caputo, MD1, Bruno Giardina, PHD2, Giovanni Ghirlanda, MD1 and Stefano A. Santini, MD2

1 Institute of Internal Medicine and Geriatrics, Catholic University School of Medicine, Rome, Italy
2 Institute of Biochemistry and Clinical Biochemistry, Catholic University School of Medicine, Rome, Italy

OBJECTIVE—Diabetes increases the risk of coronary heart disease (CHD) to a greater extent in women than in men. We investigated whether type 1 diabetic patients with short duration of disease and without complications have an altered oxidative status and whether there are differences between men and women.

RESEARCH DESIGN AND METHODS—We investigated oxidative status in 29 control subjects and 37 patients with uncomplicated type 1 diabetes with duration of 6 ± 3 years.

RESULTS—Compared with control subjects, type 1 diabetic patients had lower total plasma antioxidant capacity (TRAP) (720.3 ± 111.2 vs. 972.5 ± 97.7 µmol/l in men, P < 0.001; 579.8 ± 95.4 vs. 930.1 ± 84.2 in women, P < 0.001), higher lipid hydroperoxide (ROOH) levels (6.4 ± 2.2 vs. 2.0 ± 0.7 µmol/l in men, P < 0.001; 8.1 ± 1.9 vs. 2.2 ± 0.6 in women, P < 0.001), higher total conjugated diene (CD) levels (0.037 ± 0.003 vs. 0.033 ± 0.002 A.U. in men, P < 0.001), lower 246-nm CD levels (0.0032.± 0.0010 vs. 0.0070 ± 0.0012 A.U. in men, P < 0.001; 0.0022 ± 0.0011 vs. 0.0072 ± 0.0014 A.U. in women, P < 0.001), and higher 232-nm CD levels (0.0348 ± 0.0041 vs. 0.0257 ± 0.0022 A.U. in men, P < 0.001; 0.0346 ± 0.0031 vs. 0.0246 ± 0.0074 A.U. in women, P < 0.001). Compared with diabetic men, diabetic women had lower TRAP (P < 0.01), higher ROOH levels (P < 0.01), and lower 246-nm CD levels (P < 0.05). Plasma concentration of uric acid was significantly lower in patients with type 1 diabetes than in control subjects (3.3 ± 0.3 vs. 4.3 ± 0.2 mg/dl; P = 0.009) with a significant difference between women and men with type 1 diabetes (2.6 ± 0.3 vs. 3.9 ± 0.3, respectively; P = 0.009).

CONCLUSIONS—Our findings suggest that reduced antioxidant activity and increased oxidative stress occur early after the diagnosis of type 1 diabetes, especially in women, and this might explain, at least in part, the increased susceptibility of diabetic women to cardiovascular complications.

Abbreviations: ABTS, 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) • CD, conjugated diene • CHD, coronary heart disease • ROOH, hydroperoxide • TPP, triphenylphosphine • TRAP, total plasma antioxidant capacity


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
W. W. Chance, C. Rhee, C. Yilmaz, D. M. Dane, M. L. Pruneda, P. Raskin, and C. C.W. Hsia
Diminished Alveolar Microvascular Reserves in Type 2 Diabetes Reflect Systemic Microangiopathy
Diabetes Care, August 1, 2008; 31(8): 1596 - 1601.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. F. Walter, R. F. Jacob, R. E. Bjork, B. Jeffers, J. Buch, Y. Mizuno, R. P. Mason, and on behalf of the PREVENT Investigators
Circulating Lipid Hydroperoxides Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease: The PREVENT Study
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1196 - 1202.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y Shimoni, D Hunt, M Chuang, K. Y Chen, G Kargacin, and D. L Severson
Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat
J. Physiol., August 15, 2005; 567(1): 177 - 190.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Fauconnier, J. T. Lanner, S.-J. Zhang, P. Tavi, J. D. Bruton, A. Katz, and H. Westerblad
Insulin and Inositol 1,4,5-Trisphosphate Trigger Abnormal Cytosolic Ca2+ Transients and Reveal Mitochondrial Ca2+ Handling Defects in Cardiomyocytes of ob/ob Mice
Diabetes, August 1, 2005; 54(8): 2375 - 2381.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ceriello, L. Piconi, L. Quagliaro, Y. Wang, C. A. Schnabel, J. A. Ruggles, M. A. Gloster, D. G. Maggs, and C. Weyer
Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes
Diabetes Care, March 1, 2005; 28(3): 632 - 637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Dragsted, G Ravn-Haren, M Hansen, M Kall, V Breinholt, J Jakobsen, S. Rasmussen, A Pedersen, B Sandstrom, A Hermetter, et al.
Reply to M Serafini et al
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 532 - 534.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. M. Vincent, J. W. Russell, P. Low, and E. L. Feldman
Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
Endocr. Rev., August 1, 2004; 25(4): 612 - 628.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Ye, N. S. Metreveli, R. V. Donthi, S. Xia, M. Xu, E. C. Carlson, and P. N. Epstein
Catalase Protects Cardiomyocyte Function in Models of Type 1 and Type 2 Diabetes
Diabetes, May 1, 2004; 53(5): 1336 - 1343.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Ye, N. S. Metreveli, J. Ren, and P. N. Epstein
Metallothionein Prevents Diabetes-Induced Deficits in Cardiomyocytes by Inhibiting Reactive Oxygen Species Production
Diabetes, March 1, 2003; 52(3): 777 - 783.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.